The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|14|5|455-473

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.14, Iss.5, 2016-06, pp. : 455-473

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Allosteric Modulators for mGlu Receptors

By  

Current Neuropharmacology, Vol. 5, Iss. 3, 2007-09 ,pp. : 187-194

Bentham Science Publishers

Access to resources Recommend Favorite

mGluR5 Negative Allosteric Modulators Overview: A Medicinal Chemistry Approach Towards a Series of Novel Therapeutic Agents

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-03 ,pp. : 680-695

Bentham Science Publishers

Access to resources Recommend Favorite

Novel allosteric antagonists shed light on mglu 5 receptors and CNS disorders

By Spooren W.P.J.M.   Gasparini F.   Salt T.E.   Kuhn R.  

Trends in Pharmacological Sciences, Vol. 22, Iss. 7, 2001-07 ,pp. : 331-337

Elsevier

Access to resources Recommend Favorite

mGlu5 negative allosteric modulators: a patent review (2010 – 2012)

By Emmitte Kyle A  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 393-408

Informa Healthcare

Access to resources Recommend Favorite

Role of Group I Metabotropic Glutamate Receptors mGlu1 and mGlu5 in Nociceptive Signalling

By  

Current Neuropharmacology, Vol. 2, Iss. 4, 2004-10 ,pp. : 363-393

Bentham Science Publishers

Access to resources Recommend Favorite